Control by Oxygen of Lens Metabolism and Cataract Formation
Control by Oxygen of Lens Metabolism and Cataract Formation
批准号:
7341674
负责人:
DAVID CY BEEBE
金额:
$52.1万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-01-05 至 2009-12-31
关键词:
AffectAgeAge-MonthsAnimal ModelAnimalsApplications GrantsBiochemistryBlindnessBlood CirculationCataractCell NucleusConditionCrystalline LensDataDiabetes MellitusDiabetic RetinopathyDiseaseEnvironmentEnzymesEpithelialExposure toEyeGelGene ExpressionGene ProteinsGenesGenetic ModelsGrowthHumanHyperoxiaHypoxiaInterventionKnockout MiceLeadLens OpacitiesMeasurementMeasuresMediator of activation proteinMedicareMetabolicMetabolismMicroarray AnalysisMolecularMusNuclearOperative Surgical ProceduresOxygenPathway interactionsPatientsPolymerase Chain ReactionPropertyRateResearch PersonnelRetinaRetinalRetinal DiseasesRiskRisk FactorsShapesTestingTranscriptVitrectomyVitreous ChamberVitreous body structureVitreous humorage relatedbasecostdiabeticeye chamberfiber cellglutathione peroxidasein vivolenslens transparencynon-diabeticnormal agingoxidationpreventprogramsprotein expressionresearch studyresponseretinal ischemiatranscription factor
中文摘要
白内障(眼睛晶状体混浊)是世界上致盲的主要原因,
美国联邦医疗保险计划每年近50亿美元。核性白内障(晶状体中心混浊)是
最常见的老年性白内障。然而,这种疾病的病因还不是很清楚。
以前的研究表明,身体暴露在氧气增加的环境中是核辐射的危险因素
人类的白内障。晶状体通常存在于严重缺氧的环境中。我们发现,这些变化
眼睛中的氧气水平会影响晶状体基因和蛋白质的表达。我们还发现凝胶的损失
玻璃体结构是核性白内障的重要危险因素,并增加氧气水平。
在镜头周围。根据这些和本提案中描述的其他观察结果,我们建议
晶状体暴露于分子氧是老年性核性白内障的主要原因
晶状体核随年龄增长而逐渐浑浊。我们将检验这一假设的预测。
有两个具体的目标。首先,我们将确定氧调节晶状体基因的机制。
以及氧气水平是否直接导致核性白内障的形成。小鼠晶状体
野生型或表达稳定形式转录因子HIF1a将暴露于不同的
体内的氧气水平,然后微阵列分析和qPCR将被用来记录基因的变化
表情。这将揭示氧气改变晶状体基因表达的分子途径,从而
在低氧环境中生存的晶状体。我们还将确定是否降低氧气水平
在晶状体周围防止形成核性白内障。这将通过保持遗传上的
在较低水平的环境中,6个月龄开始发生核性白内障的改良小鼠
氧气,这会使晶状体周围的氧气水平降低-50%。如果分子氧对晶状体有贡献
氧化损伤,这种处理会延缓晶状体氧化损伤和混浊的形成。
通过测量接受视网膜手术的患者眼睛的氧气水平,我们发现氧气
玻璃体切割术后晶状体周围升高,糖尿病视网膜病变患者下降。基于
这些数据,我们将测试预测,在糖尿病患者(玻璃体中氧气含量较低),后-
玻璃体切割术白内障的进展将比非缺血性视网膜病变的患者慢。我们也
观察到长期单侧视网膜低氧的患者在其所受影响的患者中有较少的核混浊
(缺氧性)眼睛。我们将比较长期单侧视网膜病变患者双眼的核混浊。
缺血症。这项研究将检验我们的预测,即视网膜中的氧气是导致正常年龄的原因--
晶状体核相关混浊。
英文摘要
Cataract (opacification of the lens of the eye) is the primary cause of blindness in the world and costs the
US Medicare program nearly $5 billion annually. Nuclear cataract (opacification of the center of the lens) is
the most common form of age-related cataract. However, the causes of this disease are not well understood.
Previous studies showed that exposure of the body to increased oxygen is a risk factor for nuclear
cataracts in humans. The lens normally exists in a severely hypoxic environment. We found that changes in
oxygen levels in the eye influence lens gene and protein expression. We also found that loss of the gel
structure of the vitreous body is an important risk factor for nuclear cataracts and increases oxygen levels
around the lens. Based on these and other observations described in this proposal, we propose that
exposure of the lens to molecular oxygen is the primary cause of age-related nuclear cataracts and the
gradual opacification of the lens nucleus that occurs with age. We will test the predictions of this hypothesis
in two specific aims. In the first, we will identify the mechanisms by which oxygen regulates lens gene
expression and whether oxygen levels directly contribute to the formation of nuclear cataracts. Mouse lenses
that are wild type or that express stable forms of the transcription factor HIF1a will be exposed to different
levels of oxygen in vivo and then microarray analysis and qPCR will be used to document changes in gene
expression. This will reveal the molecular pathways by which oxygen alters lens gene expression, allowing
the lens to survive in a hypoxic environment. We will also determine whether reducing the oxygen levels
around the lens protects against nuclear cataract formation. This will be done by maintaining genetically
modified mice that develop nuclear cataracts beginning at 6 months of age in lower levels of ambient
oxygen, which lowers the oxygen levels around the lens by -50%. If molecular oxygen contributes to lens
oxidative damage, this treatment will delay the formation of lens oxidative damage and opacification.
By measuring oxygen levels in the eyes of patients undergoing retinal surgery we found that oxygen
around the lens is elevated after vitrectomy and decreased in patients with diabetic retinopathy. Based on
these data, we will test the prediction that, in patients with diabetes (lower oxygen in the vitreous body), post-
vitrectomy cataracts will progress more slowly than in patients with non-ischemic retinopathy. We also
observed that patients with long-standing, unilateral retinal hypoxia have less nuclear opacity in their affected
(hypoxic) eye. We will compare nuclear opacity in both eyes of patients with long-standing, unilateral retinal
ischemia. This study will test our prediction that oxygen from the retina is responsible for the "normal," age-
related opacification of the lens nucleus.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ORIGIN AND MAINTENANCE OF THE OCULAR SURFACE EPITHELIA
-
批准号:8514617
-
项目类别:
-
资助金额:$28.88万
-
财政年份:2012
-
负责人:DAVID CY BEEBE
-
依托单位:
ORIGIN AND MAINTENANCE OF THE OCULAR SURFACE EPITHELIA
-
批准号:8343336
-
项目类别:
-
资助金额:$30.4万
-
财政年份:2012
-
负责人:DAVID CY BEEBE
-
依托单位:
ORIGIN AND MAINTENANCE OF THE OCULAR SURFACE EPITHELIA
-
批准号:8675255
-
项目类别:
-
资助金额:$29.79万
-
财政年份:2012
-
负责人:DAVID CY BEEBE
-
依托单位:
POST TRANSCRIPTIONAL CONTROL OF GENE EXPRESSION IN THE LENS (LENS GENE EXPRESSION
-
批准号:8086936
-
项目类别:
-
资助金额:$40.4万
-
财政年份:2011
-
负责人:DAVID CY BEEBE
-
依托单位:
POST TRANSCRIPTIONAL CONTROL OF GENE EXPRESSION IN THE LENS (LENS GENE EXPRESSION
-
批准号:8634098
-
项目类别:
-
资助金额:$42.16万
-
财政年份:2011
-
负责人:DAVID CY BEEBE
-
依托单位:
POST TRANSCRIPTIONAL CONTROL OF GENE EXPRESSION IN THE LENS (LENS GENE EXPRESSION
-
批准号:8241900
-
项目类别:
-
资助金额:$47.8万
-
财政年份:2011
-
负责人:DAVID CY BEEBE
-
依托单位:
POST TRANSCRIPTIONAL CONTROL OF GENE EXPRESSION IN THE LENS (LENS GENE EXPRESSION
-
批准号:8445324
-
项目类别:
-
资助金额:$45.41万
-
财政年份:2011
-
负责人:DAVID CY BEEBE
-
依托单位:
Control by Oxygen of Lens Metabolism and Cataract Formation
-
批准号:7038514
-
项目类别:
-
资助金额:$55.22万
-
财政年份:2006
-
负责人:DAVID CY BEEBE
-
依托单位:
Control by Oxygen of Lens Metabolism and Cataract Formation
-
批准号:7545429
-
项目类别:
-
资助金额:$54.23万
-
财政年份:2006
-
负责人:DAVID CY BEEBE
-
依托单位:
Control by Oxygen of Lens Metabolism and Cataract Formation
-
批准号:7166096
-
项目类别:
-
资助金额:$52.22万
-
财政年份:2006
-
负责人:DAVID CY BEEBE
-
依托单位:
CONFERENCE ON MICROTECHNOLOGY IN MEDICINE AND BIOLOGY
-
批准号:6294214
-
项目类别:
-
资助金额:$1.8万
-
财政年份:2000
-
负责人:DAVID CY BEEBE
-
依托单位:
Research Training Program in the Vision Sciences
-
批准号:7497020
-
项目类别:
-
资助金额:$27.74万
-
财政年份:2000
-
负责人:DAVID CY BEEBE
-
依托单位:
Research Training Program in the Vision Sciences
-
批准号:7280413
-
项目类别:
-
资助金额:$26.08万
-
财政年份:2000
-
负责人:DAVID CY BEEBE
-
依托单位:
Research Training Program in the Vision Sciences
-
批准号:6801081
-
项目类别:
-
资助金额:$31.41万
-
财政年份:2000
-
负责人:DAVID CY BEEBE
-
依托单位:
Research Training Program in the Vision Sciences
-
批准号:6665290
-
项目类别:
-
资助金额:$30.66万
-
财政年份:2000
-
负责人:DAVID CY BEEBE
-
依托单位:
Research Training Program in the Vision Sciences
-
批准号:7682839
-
项目类别:
-
资助金额:$24.04万
-
财政年份:2000
-
负责人:DAVID CY BEEBE
-
依托单位:
Research Training Program in the Vision Sciences
-
批准号:6518713
-
项目类别:
-
资助金额:$28.96万
-
财政年份:2000
-
负责人:DAVID CY BEEBE
-
依托单位:
Research Training Program in the Vision Sciences
-
批准号:6894979
-
项目类别:
-
资助金额:$39.05万
-
财政年份:2000
-
负责人:DAVID CY BEEBE
-
依托单位:
Research Training Program in the Vision Sciences
-
批准号:6384922
-
项目类别:
-
资助金额:$23.45万
-
财政年份:2000
-
负责人:DAVID CY BEEBE
-
依托单位:
Research Training Program in the Vision Sciences
-
批准号:8327249
-
项目类别:
-
资助金额:$33.79万
-
财政年份:2000
-
负责人:DAVID CY BEEBE
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: